APO Research

APO RESEARCH · REPORT

Pemetrexed Diacid

Selected research

Industry Growth & Trends

Global Pemetrexed Diacid Industry Growth and Trends Forecast to 2032

Market perspective

The global Pemetrexed Diacid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pemetrexed Diacid include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pemetrexed Diacid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pemetrexed Diacid market size, estimates, and forecasts are presented in terms of sales volume (doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pemetrexed Diacid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pemetrexed Diacid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pemetrexed Diacid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pemetrexed Diacid Market by Company

Qilu Pharma

Nanjing Pharmaceutical Factory Co., Ltd.

Lianyungang Tengfa Bio-tech Co., Ltd.

Eli Lilly and Company

United Biotech India Pvt.Ltd.

Pemgem

Onkos

Natco Pharma Ltd

Emcure

Cytotoxic

ChemOthersapy

Beacon Pharma

Actiza Parma

Pemetrexed Diacid Segment by Type

500mg Injection

300mg Injection

200mg Injection

100mg Injection

Pemetrexed Diacid Segment by Application

Mesothelioma

Non-Small Cell Lung Cancer

Others

Pemetrexed Diacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pemetrexed Diacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500mg Injection Table 2. Major Company of 300mg Injection Table 3. Major Company of 200mg Injection Table 4. Major Company of 100mg Injection Table 5. Global Pemetrexed Diacid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 7. Global Pemetrexed Diacid Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pemetrexed Diacid Sales Market Share in Value by Type (2021-2026) Table 10. Global Pemetrexed Diacid Price by Type (2021-2026) & (US$/dose) Table 11. Global Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 12. Global Pemetrexed Diacid Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pemetrexed Diacid Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pemetrexed Diacid Sales Market Share in Value by Type (2027-2032) Table 15. Global Pemetrexed Diacid Price by Type (2027-2032) & (US$/dose) Table 16. North America Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 17. North America Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 19. Europe Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 21. Asia-Pacific Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 23. Latin America Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 25. Middle East and Africa Pemetrexed Diacid Sales by Type (2021-2026) & (US$ Million) Table 26. Pemetrexed Diacid Industry Trends Table 27. Pemetrexed Diacid Industry Drivers Table 28. Pemetrexed Diacid Industry Opportunities and Challenges Table 29. Pemetrexed Diacid Industry Restraints Table 30. Global Pemetrexed Diacid Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pemetrexed Diacid Revenue Market Share by Company (2021-2026) Table 32. Global Pemetrexed Diacid Sales by Company (2021-2026) & (doses) Table 33. Global Pemetrexed Diacid Sales Share by Company (2021-2026) Table 34. Global Pemetrexed Diacid Market Price by Company (2021-2026) & (US$/dose) Table 35. Global Pemetrexed Diacid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pemetrexed Diacid Major Company Production Sites and Headquarters Table 37. Global Pemetrexed Diacid Company, Product Type & Application Table 38. Global Pemetrexed Diacid Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pemetrexed Diacid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pemetrexed Diacid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pemetrexed Diacid Sales by Region (2021-2026) & (doses) Table 43. Global Pemetrexed Diacid Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pemetrexed Diacid Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pemetrexed Diacid Sales Market Share in Value by Region (2021-2026) Table 46. Global Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 47. Global Pemetrexed Diacid Sales by Region (2027-2032) & (doses) Table 48. Global Pemetrexed Diacid Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pemetrexed Diacid Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pemetrexed Diacid Sales Market Share in Value by Region (2027-2032) Table 51. Global Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 52. Global Pemetrexed Diacid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 54. Global Pemetrexed Diacid Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pemetrexed Diacid Sales Market Share in Value by Application (2021-2026) Table 57. Global Pemetrexed Diacid Price by Application (2021-2026) & (US$/dose) Table 58. Global Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 59. Global Pemetrexed Diacid Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pemetrexed Diacid Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pemetrexed Diacid Sales Market Share in Value by Application (2027-2032) Table 62. Global Pemetrexed Diacid Price by Application (2027-2032) & (US$/dose) Table 63. North America Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 64. North America Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 66. Europe Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 68. Asia-Pacific Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 70. Latin America Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 72. Middle East and Africa Pemetrexed Diacid Sales by Application (2021-2026) & (US$ Million) Table 73. Qilu Pharma Company Information Table 74. Qilu Pharma Business Overview Table 75. Qilu Pharma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 76. Qilu Pharma Pemetrexed Diacid Product Portfolio Table 77. Qilu Pharma Recent Development Table 78. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 79. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 80. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 81. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio Table 82. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 83. Lianyungang Tengfa Bio-tech Co., Ltd. Company Information Table 84. Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview Table 85. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 86. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio Table 87. Lianyungang Tengfa Bio-tech Co., Ltd. Recent Development Table 88. Eli Lilly and Company Company Information Table 89. Eli Lilly and Company Business Overview Table 90. Eli Lilly and Company Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 91. Eli Lilly and Company Pemetrexed Diacid Product Portfolio Table 92. Eli Lilly and Company Recent Development Table 93. United Biotech India Pvt.Ltd. Company Information Table 94. United Biotech India Pvt.Ltd. Business Overview Table 95. United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 96. United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio Table 97. United Biotech India Pvt.Ltd. Recent Development Table 98. Pemgem Company Information Table 99. Pemgem Business Overview Table 100. Pemgem Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 101. Pemgem Pemetrexed Diacid Product Portfolio Table 102. Pemgem Recent Development Table 103. Onkos Company Information Table 104. Onkos Business Overview Table 105. Onkos Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 106. Onkos Pemetrexed Diacid Product Portfolio Table 107. Onkos Recent Development Table 108. Natco Pharma Ltd Company Information Table 109. Natco Pharma Ltd Business Overview Table 110. Natco Pharma Ltd Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 111. Natco Pharma Ltd Pemetrexed Diacid Product Portfolio Table 112. Natco Pharma Ltd Recent Development Table 113. Emcure Company Information Table 114. Emcure Business Overview Table 115. Emcure Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 116. Emcure Pemetrexed Diacid Product Portfolio Table 117. Emcure Recent Development Table 118. Cytotoxic Company Information Table 119. Cytotoxic Business Overview Table 120. Cytotoxic Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 121. Cytotoxic Pemetrexed Diacid Product Portfolio Table 122. Cytotoxic Recent Development Table 123. ChemOthersapy Company Information Table 124. ChemOthersapy Business Overview Table 125. ChemOthersapy Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 126. ChemOthersapy Pemetrexed Diacid Product Portfolio Table 127. ChemOthersapy Recent Development Table 128. Beacon Pharma Company Information Table 129. Beacon Pharma Business Overview Table 130. Beacon Pharma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 131. Beacon Pharma Pemetrexed Diacid Product Portfolio Table 132. Beacon Pharma Recent Development Table 133. Actiza Parma Company Information Table 134. Actiza Parma Business Overview Table 135. Actiza Parma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 136. Actiza Parma Pemetrexed Diacid Product Portfolio Table 137. Actiza Parma Recent Development Table 138. North America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 139. North America Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 140. North America Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 141. North America Pemetrexed Diacid Sales Forecast by Country (2027-2032) & (doses) Table 142. North America Pemetrexed Diacid Sales Market Share Forecast by Country (2027-2032) Table 143. North America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Pemetrexed Diacid Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Pemetrexed Diacid Market Share by Country (2021-2026) Table 146. North America Pemetrexed Diacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Pemetrexed Diacid Market Share Forecast by Country (2027-2032) Table 148. Europe Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 149. Europe Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 150. Europe Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 151. Europe Pemetrexed Diacid Sales Forecast by Country (2027-2032) & (doses) Table 152. Europe Pemetrexed Diacid Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Pemetrexed Diacid Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Pemetrexed Diacid Market Share by Country (2021-2026) Table 156. Europe Pemetrexed Diacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Pemetrexed Diacid Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 160. Asia-Pacific Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Pemetrexed Diacid Sales Forecast by Country (2027-2032) & (doses) Table 162. Asia-Pacific Pemetrexed Diacid Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Pemetrexed Diacid Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Pemetrexed Diacid Market Share by Country (2021-2026) Table 166. Asia-Pacific Pemetrexed Diacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Pemetrexed Diacid Market Share Forecast by Country (2027-2032) Table 168. Latin America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 169. Latin America Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 170. Latin America Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 171. Latin America Pemetrexed Diacid Sales Forecast by Country (2027-2032) & (doses) Table 172. Latin America Pemetrexed Diacid Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Pemetrexed Diacid Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Pemetrexed Diacid Market Share by Country (2021-2026) Table 176. Latin America Pemetrexed Diacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Pemetrexed Diacid Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 180. Middle East and Africa Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Pemetrexed Diacid Sales Forecast by Country (2027-2032) & (doses) Table 182. Middle East and Africa Pemetrexed Diacid Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Pemetrexed Diacid Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Pemetrexed Diacid Market Share by Country (2021-2026) Table 186. Middle East and Africa Pemetrexed Diacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Pemetrexed Diacid Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Pemetrexed Diacid Distributors List Table 191. Pemetrexed Diacid Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Pemetrexed Diacid Image Figure 2. Global Pemetrexed Diacid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Diacid Market Size (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Diacid Sales (2021-2032) & (doses) Figure 5. 500mg Injection Image Figure 6. Global 500mg Injection Sales YoY Growth (2021-2032) & (doses) Figure 7. 300mg Injection Image Figure 8. Global 300mg Injection Sales YoY Growth (2021-2032) & (doses) Figure 9. 200mg Injection Image Figure 10. Global 200mg Injection Sales YoY Growth (2021-2032) & (doses) Figure 11. 100mg Injection Image Figure 12. Global 100mg Injection Sales YoY Growth (2021-2032) & (doses) Figure 13. Global Pemetrexed Diacid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pemetrexed Diacid Market Share by Type 2025 VS 2032 Figure 15. North America Pemetrexed Diacid Sales Market Share in Volume by Type in 2025 Figure 16. North America Pemetrexed Diacid Sales Market Share in Value by Type in 2025 Figure 17. Europe Pemetrexed Diacid Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pemetrexed Diacid Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pemetrexed Diacid Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pemetrexed Diacid Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pemetrexed Diacid Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pemetrexed Diacid Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pemetrexed Diacid Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pemetrexed Diacid Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pemetrexed Diacid Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Mesothelioma Image Figure 28. Global Mesothelioma Sales YoY Growth (2021-2032) & (doses) Figure 29. Non-Small Cell Lung Cancer Image Figure 30. Global Non-Small Cell Lung Cancer Sales YoY Growth (2021-2032) & (doses) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (doses) Figure 33. Global Pemetrexed Diacid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pemetrexed Diacid Market Share by Application 2025 VS 2032 Figure 35. North America Pemetrexed Diacid Sales Market Share in Volume by Application in 2025 Figure 36. North America Pemetrexed Diacid Sales Market Share in Value by Application in 2025 Figure 37. Europe Pemetrexed Diacid Sales Market Share in Volume by Application in 2025 Figure 38. Europe Pemetrexed Diacid Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Pemetrexed Diacid Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Pemetrexed Diacid Sales Market Share in Value by Application in 2025 Figure 41. Latin America Pemetrexed Diacid Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Pemetrexed Diacid Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Pemetrexed Diacid Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Pemetrexed Diacid Sales Market Share in Value by Application in 2025 Figure 45. North America Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 46. North America Pemetrexed Diacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Pemetrexed Diacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 50. Europe Pemetrexed Diacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Pemetrexed Diacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 54. Asia-Pacific Pemetrexed Diacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Pemetrexed Diacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 58. Latin America Pemetrexed Diacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Pemetrexed Diacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 62. Middle East and Africa Pemetrexed Diacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Pemetrexed Diacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pemetrexed Diacid Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Pemetrexed Diacid Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg Injection
  • 300mg Injection
  • 200mg Injection
  • 100mg Injection
Applications
  • Mesothelioma
  • Non-Small Cell Lung Cancer
  • Others
Companies covered
  • Qilu Pharma
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Lianyungang Tengfa Bio-tech Co., Ltd.
  • Eli Lilly and Company
  • United Biotech India Pvt.Ltd.
  • Pemgem
  • Onkos
  • Natco Pharma Ltd
  • Emcure
  • Cytotoxic
  • ChemOthersapy
  • Beacon Pharma
  • Actiza Parma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemetrexed Diacid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pemetrexed Diacid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pemetrexed Diacid Market by Type
  6. 1.3.1 500mg Injection
  7. 1.3.2 300mg Injection
  8. 1.3.3 200mg Injection
  9. 1.3.4 100mg Injection
  10. 1.4 Global Pemetrexed Diacid Market Size by Type
  11. 1.4.1 Global Pemetrexed Diacid Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pemetrexed Diacid Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pemetrexed Diacid Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pemetrexed Diacid Industry Trends
  2. 2.2 Pemetrexed Diacid Industry Drivers
  3. 2.3 Pemetrexed Diacid Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Diacid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pemetrexed Diacid Revenue (2021-2026)
  2. 3.2 Global Top Players by Pemetrexed Diacid Sales (2021-2026)
  3. 3.3 Global Top Players by Pemetrexed Diacid Price (2021-2026)
  4. 3.4 Global Pemetrexed Diacid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pemetrexed Diacid Major Company Production Sites & Headquarters
  6. 3.6 Global Pemetrexed Diacid Company, Product Type & Application
  7. 3.7 Global Pemetrexed Diacid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pemetrexed Diacid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pemetrexed Diacid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pemetrexed Diacid Tier 1, Tier 2, and Tier 3
4 Pemetrexed Diacid Regional Status and Outlook
  1. 4.1 Global Pemetrexed Diacid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pemetrexed Diacid Historic Market Size by Region
  3. 4.2.1 Global Pemetrexed Diacid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pemetrexed Diacid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pemetrexed Diacid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pemetrexed Diacid Forecasted Market Size by Region
  7. 4.3.1 Global Pemetrexed Diacid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pemetrexed Diacid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pemetrexed Diacid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pemetrexed Diacid by Application
  1. 5.1 Pemetrexed Diacid Market by Application
  2. 5.1.1 Mesothelioma
  3. 5.1.2 Non-Small Cell Lung Cancer
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Diacid Market Size by Application
  6. 5.2.1 Global Pemetrexed Diacid Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pemetrexed Diacid Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pemetrexed Diacid Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Qilu Pharma
  2. 6.1.1 Qilu Pharma Company Information
  3. 6.1.2 Qilu Pharma Business Overview
  4. 6.1.3 Qilu Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
  6. 6.1.5 Qilu Pharma Recent Developments
  7. 6.2 Nanjing Pharmaceutical Factory Co., Ltd.
  8. 6.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  9. 6.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  10. 6.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
  12. 6.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  13. 6.3 Lianyungang Tengfa Bio-tech Co., Ltd.
  14. 6.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
  15. 6.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
  16. 6.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
  18. 6.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
  19. 6.4 Eli Lilly and Company
  20. 6.4.1 Eli Lilly and Company Company Information
  21. 6.4.2 Eli Lilly and Company Business Overview
  22. 6.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
  24. 6.4.5 Eli Lilly and Company Recent Developments
  25. 6.5 United Biotech India Pvt.Ltd.
  26. 6.5.1 United Biotech India Pvt.Ltd. Company Information
  27. 6.5.2 United Biotech India Pvt.Ltd. Business Overview
  28. 6.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
  30. 6.5.5 United Biotech India Pvt.Ltd. Recent Developments
  31. 6.6 Pemgem
  32. 6.6.1 Pemgem Company Information
  33. 6.6.2 Pemgem Business Overview
  34. 6.6.3 Pemgem Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pemgem Pemetrexed Diacid Product Portfolio
  36. 6.6.5 Pemgem Recent Developments
  37. 6.7 Onkos
  38. 6.7.1 Onkos Company Information
  39. 6.7.2 Onkos Business Overview
  40. 6.7.3 Onkos Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Onkos Pemetrexed Diacid Product Portfolio
  42. 6.7.5 Onkos Recent Developments
  43. 6.8 Natco Pharma Ltd
  44. 6.8.1 Natco Pharma Ltd Company Information
  45. 6.8.2 Natco Pharma Ltd Business Overview
  46. 6.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
  48. 6.8.5 Natco Pharma Ltd Recent Developments
  49. 6.9 Emcure
  50. 6.9.1 Emcure Company Information
  51. 6.9.2 Emcure Business Overview
  52. 6.9.3 Emcure Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Emcure Pemetrexed Diacid Product Portfolio
  54. 6.9.5 Emcure Recent Developments
  55. 6.10 Cytotoxic
  56. 6.10.1 Cytotoxic Company Information
  57. 6.10.2 Cytotoxic Business Overview
  58. 6.10.3 Cytotoxic Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
  60. 6.10.5 Cytotoxic Recent Developments
  61. 6.11 ChemOthersapy
  62. 6.11.1 ChemOthersapy Company Information
  63. 6.11.2 ChemOthersapy Business Overview
  64. 6.11.3 ChemOthersapy Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
  66. 6.11.5 ChemOthersapy Recent Developments
  67. 6.12 Beacon Pharma
  68. 6.12.1 Beacon Pharma Company Information
  69. 6.12.2 Beacon Pharma Business Overview
  70. 6.12.3 Beacon Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
  72. 6.12.5 Beacon Pharma Recent Developments
  73. 6.13 Actiza Parma
  74. 6.13.1 Actiza Parma Company Information
  75. 6.13.2 Actiza Parma Business Overview
  76. 6.13.3 Actiza Parma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
  78. 6.13.5 Actiza Parma Recent Developments
7 North America by Country
  1. 7.1 North America Pemetrexed Diacid Sales by Country
  2. 7.1.1 North America Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pemetrexed Diacid Sales by Country (2021-2026)
  4. 7.1.3 North America Pemetrexed Diacid Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pemetrexed Diacid Market Size by Country
  6. 7.2.1 North America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pemetrexed Diacid Market Size by Country (2021-2026)
  8. 7.2.3 North America Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pemetrexed Diacid Sales by Country
  2. 8.1.1 Europe Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pemetrexed Diacid Sales by Country (2021-2026)
  4. 8.1.3 Europe Pemetrexed Diacid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pemetrexed Diacid Market Size by Country
  6. 8.2.1 Europe Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pemetrexed Diacid Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pemetrexed Diacid Sales by Country
  2. 9.1.1 Asia-Pacific Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pemetrexed Diacid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pemetrexed Diacid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pemetrexed Diacid Market Size by Country
  6. 9.2.1 Asia-Pacific Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pemetrexed Diacid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pemetrexed Diacid Sales by Country
  2. 10.1.1 South America Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pemetrexed Diacid Sales by Country (2021-2026)
  4. 10.1.3 South America Pemetrexed Diacid Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pemetrexed Diacid Market Size by Country
  6. 10.2.1 South America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pemetrexed Diacid Market Size by Country (2021-2026)
  8. 10.2.3 South America Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pemetrexed Diacid Sales by Country
  2. 11.1.1 Middle East and Africa Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pemetrexed Diacid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pemetrexed Diacid Market Size by Country
  6. 11.2.1 Middle East and Africa Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pemetrexed Diacid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pemetrexed Diacid Value Chain Analysis
  2. 12.1.1 Pemetrexed Diacid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pemetrexed Diacid Production Mode & Process
  7. 12.2 Pemetrexed Diacid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pemetrexed Diacid Distributors
  10. 12.2.3 Pemetrexed Diacid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research